Vor Biopharma Inc. (VOR)

Vor Biopharma Stock Forecast

Stock Price Forecast

The 6 analysts that cover Vor Biopharma stock have a consensus rating of "Buy" and an average price target of $85.33, which forecasts a 216.92% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $160.

Price Target: $85.33 (+216.92%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$85.33	$100	$160
Change	-70.29%	+216.92%	+271.40%	+494.24%

Analyst Ratings

The average analyst rating for Vor Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	1	2	2	2	2	2
Buy	4	2	2	2	2	2
Hold	2	3	3	3	3	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jack Allen Baird	Baird	Hold → Buy Upgrades $20 → $64	Hold → Buy	Upgrades	$20 → $64	+137.70%	Oct 15, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $60	Strong Buy	Reiterates	$60	+122.84%	Aug 14, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $60	Hold → Strong Buy	Upgrades	$60	+122.84%	Jun 30, 2025
Jack Allen Baird	Baird	Hold Maintains $5 → $20	Hold	Maintains	$5 → $20	-25.72%	Jun 27, 2025
David Nierengarten Wedbush	Wedbush	Hold Reiterates $8	Hold	Reiterates	$8	-70.29%	Jun 26, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -55.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-4,611.25	-41.95	-46.57	-35.08	-34.03	-55.71	-7.05
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-14.07	-2.05
Avg	-55.71	-7.05
Low	-81.23	-11.76

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.